M. L. Contreras

Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus.

R. Rosales, Tania Navarro, Carlos Manuel Corona Gutierrez, 2004, Human gene therapy.

MVA E2 Recombinant Vaccine in the Treatment of Human Papillomavirus Infection in Men Presenting Intraurethral Flat Condyloma

R. Rosales, M. L. Contreras, E. Zea, 2012, BioDrugs.

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine

R. Rosales, E. Garc, J. Gónzalez-Sánchez, 2006, Cancer Gene Therapy.